• 1
    Nathan PE , Gorman JM (eds). A Guide to Treatments That Work. Oxford University Press, New York, 2007.
  • 2
    Mersch PP, Emmelkamp PM, Lips C. Social phobia: Individual response patterns and the long-term effects of behavioral and cognitive interventions. A follow-up study. Behav. Res. Ther. 1991; 29: 357362.
  • 3
    Liebowitz MR, Heimberg RG, Schneier FR et al. Cognitive-behavioral group therapy versus phenelzine in social phobia: Long-term outcome. Depress. Anxiety 1999; 10: 8998.
  • 4
    Allgulander C, Nilsson B. A prospective study of 86 new patients with social anxiety disorder. Acta Psychiatr. Scand. 2001; 103: 447452.
  • 5
    Sutherland SM, Tupler LA, Colket JT, Davidson JR. A 2-year follow-up of social phobia. Status after a brief medication trial. J. Nerv. Ment. Dis. 1996; 184: 731738.
  • 6
    Stein DJ, Versiani M, Hair T, Kumar R. Efficacy of paroxetine for relapse prevention in social anxiety disorder: A 24-week study. Arch. Gen. Psychiatry 2002; 59: 11111118.
  • 7
    Gaston JE, Abbott MJ, Rapee RM, Neary SA. Do empirically supported treatments generalize to private practice? A benchmark study of a cognitive-behavioural group treatment programme for social phobia. Br. J. Clin. Psychol. 2006; 45: 3348.
  • 8
    Hunt C, Andrews G. Long-term outcome of panic disorder and social phobia. J. Anxiety Disord. 1998; 12: 395406.
  • 9
    Shafran R, Clark DM, Fairburn CG et al. Mind the gap: Improving the dissemination of CBT. Behav. Res. Ther. 2009; 47: 902909.
  • 10
    Keller MB. Social anxiety disorder clinical course and outcome: Review of Harvard/Brown Anxiety Research Project (HARP) findings. J. Clin. Psychiatry 2006; 67 (Suppl. 12): 1419.
  • 11
    Bruce SE, Yonkers KA, Otto MW et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. Am. J. Psychiatry 2005; 162: 11791187.
  • 12
    Stein MB, Torgrud LJ, Walker JR. Social phobia symptoms, subtypes, and severity: Findings from a community survey. Arch. Gen. Psychiatry 2000; 57: 10461052.
  • 13
    Andrews G, Creamer M, Crino R, Hunt C, Lampe L, Page A. The Treatment of Anxiety Disorders: Clinician Guides and Patient Manuals. Cambridge University Press, Sydney, 2002.
  • 14
    Clark DM, Wells A. A cognitive model of social phobia. In: Heimberg RG , Liebowitz MR , Hope DA , Schneier FR (eds). Social Phobia: Diagnosis, Assessment, and Treatment. Guilford Press, New York, 1995; 6993.
  • 15
    Furukawa TA, Chen J, Watanabe N et al. Videotaped experiments to drop safety behaviors and self-focused attention for patients with social anxiety disorder: Do they change subjective and objective evaluations of anxiety and performance? J. Behav. Ther. Exp. Psychiatry 2009; 40: 202210.
  • 16
    Chen J, Furukawa TA, Nakano Y et al. Video feedback with peer ratings in naturalistic anxiety-provoking situations for social anxiety disorder: Preliminary report. J. Behav. Ther. Exp. Psychiatry 2009; 41: 610.
  • 17
    Chen J, Nakano Y, Ietzugu T et al. Group cognitive behavior therapy for Japanese patients with social anxiety disorder: Preliminary outcomes and their predictors. BMC Psychiatry 2007; 7: 69.
  • 18
    Kanai Y, Sasakawa S, Chen J, Suzuki S, Shimada H, Sakano Y. Development and validation of the Japanese version of Social Phobia Scale and Social Interactin Anxiety Scale. Shinshin-Igaku (Jpn.J. Psychosom. Med.) 2004; 44: 841850 (in Japanese).
  • 19
    Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behav. Res. Ther. 1979; 17: 263267.
  • 20
    Arimura T, Harai H, Nakashima K, Kumano H, Kubo C. Japanese version of fear questionnare: Reliability and validity. In: Iwamoto T (ed.). 26th Annual Meeting of Japanese Association of Behavior Therapy, Sapporo, 2000 (in Japanese).
  • 21
    Asakura S, Inoue S, Sasaki F et al. Reliability and validity of the Japanese version of the Liebowitz Social Anxiety Scale. Seishin Igaku (Clin. Psychiatry) 2002; 44: 10771084 (in Japanese).
  • 22
    Derogatis LR. SCL-90-R: Administration, Scoring and Procedures Manual-II for the Revised Version and Other Instruments of the Psychopathology Rating Scale Series. Clinical Psychometric Research, Inc., Towson, MD, 1992.
  • 23
    Furukawa T, Nakanishi M, Sakurai A, Suzuki Y, Suzuki-Moore A, Hamanaka T. Effects of ethyl loflazepate in mood and neurosis-related disorders (ICD-10 JCM): Changes in SCL-90-R subscale scores. Rinsho Seishinigaku (Clin. Psychiatry) 1996; 25: 233240 (in Japanese).
  • 24
    Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: A simple measure of impairment in functioning. Br. J. Psychiatry 2002; 180: 461464.
  • 25
    Nakano Y, Lee K, Noda Y et al. Cognitive-behavior therapy for Japanese patients with panic disorder: Acute phase and one-year follow-up results. Psychiatry Clin. Neurosci. 2008; 62: 313321.
  • 26
    Cohen J. Statistical Power Analysis in the Behavioral Sciences. Erlbaum, Hillsdale, NJ, 1988.
  • 27
    Yonkers KA, Bruce SE, Dyck IR, Keller MB. Chronicity, relapse, and illness–course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. Depress. Anxiety 2003; 17: 173179.
  • 28
    DeWit DJ, Ogborne A, Offord DR, MacDonald K. Antecedents of the risk of recovery from DSM-III-R social phobia. Psychol. Med. 1999; 29: 569582.
  • 29
    Heimberg RG, Liebowitz MR, Hope DA et al. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch. Gen. Psychiatry 1998; 55: 11331141.
  • 30
    Stangier U, Heidenreich T, Peitz M, Lauterbach W, Clark DM. Cognitive therapy for social phobia: Individual versus group treatment. Behav. Res. Ther. 2003; 41: 9911007.
  • 31
    Mortberg E, Clark DM, Sundin O, Aberg Wistedt A. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: A randomized controlled trial. Acta Psychiatr. Scand. 2007; 115: 142154.
  • 32
    Reich J, Goldenberg I, Goisman R, Vasile R, Keller M. A prospective, follow-along study of the course of social phobia: II. Testing for basic predictors of course. J. Nerv. Ment. Dis. 1994; 182: 297301.
  • 33
    Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav. Res. Ther. 1998; 36: 455470.
  • 34
    Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? J. Clin. Psychiatry 2006; 67: 14281434.
  • 35
    Clark DM, Ehlers A, McManus F et al. Cognitive therapy versus fluoxetine in generalized social phobia: A randomized placebo-controlled trial. J. Consult. Clin. Psychol. 2003; 71: 10581067.
  • 36
    Clark DM, Ehlers A, Hackmann A et al. Cognitive therapy versus exposure and applied relaxation in social phobia: A randomized controlled trial. J. Consult. Clin. Psychol. 2006; 74: 568578.